Cholesterol acetate/randomly methylated-β-cyclodextrin (RAMEB) complex possesses potential opportunities for studying cholesterol acetate metabolism and transport in biomedical research.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.